5-(3,4-dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin has been researched along with 5-phenyl-5-(4-hydroxyphenyl)hydantoin glucuronide in 1 studies
| Studies (5-(3,4-dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin) | Trials (5-(3,4-dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin) | Recent Studies (post-2010) (5-(3,4-dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin) | Studies (5-phenyl-5-(4-hydroxyphenyl)hydantoin glucuronide) | Trials (5-phenyl-5-(4-hydroxyphenyl)hydantoin glucuronide) | Recent Studies (post-2010) (5-phenyl-5-(4-hydroxyphenyl)hydantoin glucuronide) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 8 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aliwarga, T; Brundage, RC; Cloyd, JC; Goel, V; Leppik, IE; Marino, SE; Remmel, RP | 1 |
1 other study(ies) available for 5-(3,4-dihydroxy-1,5-cyclohexadien-1-yl)-5-phenylhydantoin and 5-phenyl-5-(4-hydroxyphenyl)hydantoin glucuronide
| Article | Year |
|---|---|
Excretion of the principal urinary metabolites of phenytoin and absolute oral bioavailability determined by use of a stable isotope in patients with epilepsy.
Topics: Adult; Aged; Aged, 80 and over; Anticonvulsants; Biological Availability; Chromatography, High Pressure Liquid; Drug Monitoring; Epilepsy; Female; Humans; Isotope Labeling; Male; Middle Aged; Phenytoin; Young Adult | 2011 |